Australia markets closed

NFL Biosciences SA (82F.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.3450-0.1950 (-7.13%)
As of 08:07AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 25.43M
Enterprise value 22.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)69.78
Enterprise value/revenue N/A
Enterprise value/EBITDA -14.21

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-16.70%
S&P500 52-week change 324.78%
52-week high 33.1100
52-week low 30.9080
50-day moving average 32.2037
200-day moving average 31.8785

Share statistics

Avg vol (3-month) 3208
Avg vol (10-day) 3N/A
Shares outstanding 59.61M
Implied shares outstanding 610.4M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends N/A
Most-recent quarter (mrq)N/A

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)-0.4600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A